Ajanta Pharma decides to buyback again

The Company’s board is scheduled to meet on December 28, 2021 to take the decision. Key points to note – This is 3rd year in a row. Previous ones being Jan-Mar 2019 and Nov-Dec 2020. Jan – Mar 2019: Rs 100 crore at Rs 1,300 per share as against the then prevailing price of around … Read more

LUPIN enters into the diagnostics business

Lupin announced the formal launch of it’s diagnostics business as part of it’s strategy to provide integrated healthcare in India. Key points to note – The business is housed under a wholly owned subsidiary, Lupin Diagnostics. The company launched operations with 11 labs including a 45,000 square feet national reference lab in Navi Mumbai and … Read more

Moderna, BioNTech plunge as Bernie Sanders slams ‘obscene’ profits and tells drug makers to share COVID-19 vaccines with the world

Moderna and BioNTech plunged more than 16% on Monday amid a critical tweet from Senator Bernie Sanders. Sanders highlighted the surge in the companies’ stock prices after the Omicron variant was identified. “It’s time for these pharmaceutical companies to share their vaccines with the world and start controlling their greed,” Sanders tweeted. Shares of COVID-19 … Read more

Eris Lifesciences enters into insulin segment

Eris has formed a JV with MJ Biopharm for this purpose. Key points to note – Eris will hold 70% of the JV and MJ 30%. MJ is also getting Rs 15 crore as one time lump sum licence fee. MJ will be responsible for development of products and Eris marketing of those. JV seems … Read more